Leukocyte count as a predictor of death during remission induction in acute myeloid leukemia. (Q53604032)

16 May 2018

title

Leukocyte count as a predictor of death during remission induction in acute myeloid leukemia. (English)

1 reference

16 May 2018

1 reference

Greenwood MJ

1

1 reference

16 May 2018

Seftel MD

2

1 reference

16 May 2018

Richardson C

3

1 reference

16 May 2018

Barbaric D

4

1 reference

16 May 2018

Barnett MJ

5

1 reference

16 May 2018

Bruyere H

6

1 reference

16 May 2018

Forrest DL

7

1 reference

16 May 2018

Horsman DE

8

1 reference

16 May 2018

Smith C

9

1 reference

16 May 2018

Song K

10

1 reference

16 May 2018

Sutherland HJ

11

1 reference

16 May 2018

Toze CL

12

1 reference

16 May 2018

Nevill TJ

13

1 reference

16 May 2018

Nantel SH

14

1 reference

16 May 2018

Hogge DE

15

1 reference

16 May 2018

publication date

1 July 2006

1 reference

16 May 2018

published in

Leukemia & Lymphoma

1 reference

16 May 2018

volume

47

1 reference

16 May 2018

issue

7

1 reference

16 May 2018

page(s)

1245-1252

1 reference

16 May 2018

Principal results of the Medical Research Council's 8th acute myeloid leukaemia trial

cites work

1 reference

https://api.crossref.org/works/10.1080%2F10428190600572673

Early deaths and treatment-related mortality in children undergoing therapy for acute myeloid leukemia: analysis of the multicenter clinical trials AML-BFM 93 and AML-BFM 98.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190600572673

Salvage therapy in refractory acute myeloid leukemia: prediction of outcome based on analysis of prognostic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190600572673

Prognostic significance of activating FLT3 mutations in younger adults (16 to 60 years) with acute myeloid leukemia and normal cytogenetics: a study of the AML Study Group Ulm.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190600572673

Acute myeloblastic leukemia with hyperleukocytosis: risk factors for early mortality in induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190600572673

Features affecting outcome during remission induction of acute myeloid leukaemia in 619 adult patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190600572673

The prognostic value of cytogenetics is reinforced by the kind of induction/consolidation therapy in influencing the outcome of acute myeloid leukemia--analysis of 848 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190600572673

Respiratory distress of hyperleukocytic granulocytic leukemias

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190600572673

Reducing mortality associated with immediate treatment complications of adult leukemias

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190600572673

Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190600572673

Fulminant tumour lysis syndrome in acute myelogenous leukaemia with inv(16)(p13;q22).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190600572673

Basic principles of ROC analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190600572673

Intensive chemotherapy with idarubicin, cytarabine, etoposide, and G-CSF priming in patients with advanced myelodysplastic syndrome and high-risk acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190600572673

Co-existence of thrombocytopenia and hyperleukocytosis ('critical period') as a risk factor of haemorrhage into the central nervous system in patients with acute leukaemias

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190600572673

The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the Unite

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190600572673

Improved outcome in adult acute myeloid leukemia is almost entirely restricted to young patients and associated with stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190600572673

Randomized comparison of double induction and timed-sequential induction to a "3 + 7" induction in adults with AML: long-term analysis of the Acute Leukemia French Association (ALFA) 9000 study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190600572673

10.1080/10428190600572673

21 January 2018

Identifiers

DOI

1 reference

16 May 2018

1 reference

16 May 2018